FVII or FVIIa variants having increased clotting activity

Details for Australian Patent Application No. 2003266931 (hide)

International Classifications

Event Publications

8 January 2004 Complete Application Filed

Priority application(s): 60/414,836 30.09.02 US; 60/479,642 19.06.03 US

20 May 2004 Application Open to Public Inspection

Published as AU-B-2003266931

13 November 2008 Assignment before Grant

Maxygen Holdings Ltd. The application has been assigned to Bayer HealthCare LLC

21 January 2010 Application Accepted

Published as AU-B-2003266931

20 May 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.